As one of the most commonly activated pathways in human cancers, the aberrant PI3K/AKT signaling pathway resulted from diverse alterations such as Ras mutation has multiple downstream effects on cellular metabolism including glycolysis, through either direct regulation of glucose uptake or key steps in glycolysis via the phosphorylation and activation of specific glycolytic enzymes [143, 144]. Here, AKT1 is linked to cancer.